论文部分内容阅读
目的 :探讨合并动门静脉瘘的原发性肝癌的介入治疗。方法 :对由AFP、B超、CT诊断的原发性肝癌 10 0例施行了肝动脉内化学药物栓塞治疗 ,治疗前均行数字减影血管造影 (DSA)检查。结果 :48例合并动门静脉瘘 (4 8.0 % ) ,其中 17例同时合并有门脉癌栓。治疗后AFP均有下降 ,2 9例肿瘤缩小 (6 0 .4% ) ,12例肿瘤增大 (2 5 .0 % ) ,7例改变不明显。未发生严重肝功能损害。结论 :肝癌合并动门静脉瘘影响疗效 ,但对其仍应积极治疗。
Objective: To investigate the interventional treatment of primary liver cancer with arteriovenous fistula. Methods: Hepatic arterial chemoembolization was performed in 100 cases of primary liver cancer diagnosed by AFP, B ultrasound and CT, and digital subtraction angiography (DSA) was performed before treatment. Results: 48 cases of arteriovenous fistula (4 8.0%), of which 17 cases also had portal vein thrombosis. After treatment, AFP decreased, 29 cases of tumor shrinkage (60.4%), 12 cases of tumor (25.0%), 7 cases of change was not obvious. No serious hepatic impairment occurred. Conclusion: The effect of arteriovenous fistula in the treatment of hepatocellular carcinoma is still active, but it should be treated actively.